Cargando…

Investigating two versus three doses of mRNA vaccine in patients with cirrhosis

Detalles Bibliográficos
Autor principal:	Hindson, Jordan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	In Brief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638284/ https://www.ncbi.nlm.nih.gov/pubmed/36333545 http://dx.doi.org/10.1038/s41575-022-00711-w

Ejemplares similares

Immunosuppressive IBD drugs and COVID-19 vaccine immunogenicity
por: Hindson, Jordan
Publicado: (2022)

Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination
por: Chiang, Teresa PY, et al.
Publicado: (2022)

Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
por: Chavarot, Nathalie, et al.
Publicado: (2021)

Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
por: Tsipotis, Evangelos, et al.
Publicado: (2023)

SARS-CoV-2 in patients with chronic liver disease
por: Hindson, Jordan
Publicado: (2020)

Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis
por: John, Binu V., et al.
Publicado: (2022)

Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccine
por: de Nattes, Tristan, et al.
Publicado: (2022)

Intelligent and autonomous magnetic endoscopy
por: Hindson, Jordan
Publicado: (2020)

Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose
por: Tuong, Linh-An C, et al.
Publicado: (2021)

Second-dose mRNA COVID-19 vaccine safety in patients with immediate reactions after the first dose: A case series
por: Iaboni, Aled, et al.
Publicado: (2022)

Durability of Antibody Response Six Months After Two-Dose SARS-CoV-2 mRNA Vaccination in Patients with Cirrhosis
por: Hughes, Robert M., et al.
Publicado: (2023)

Multiple sclerosis relapses not associated with mRNA COVID-19 vaccine
por: Fyfe, Ian
Publicado: (2021)

Comparison of the mucosal and systemic antibody responses in Covid-19 recovered patients with one dose of mRNA vaccine and unexposed subjects with three doses of mRNA vaccines
por: Liu, Shaojun, et al.
Publicado: (2023)

Preclinical data from SARS-CoV-2 mRNA vaccine
por: Vabret, Nicolas
Publicado: (2020)

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients
por: Hammer, Helly, et al.
Publicado: (2022)

Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination
por: Funakoshi, Yohei, et al.
Publicado: (2022)

Immunogenicity of Third-dose BNT162b2 mRNA Vaccine Following Two Doses of ChAdOx1 in Health Care Workers: A Prospective Longitudinal Study
por: Kim, Jung-Ah, et al.
Publicado: (2022)

SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine
por: Clémenceau, Béatrice, et al.
Publicado: (2022)

Is the mRNA COVID-19 Vaccine Safe in Patients With a Prior History of Myocarditis?
por: Shahid, Rida, et al.
Publicado: (2023)

Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients
por: Hoffman, T.W., et al.
Publicado: (2022)

Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea
por: Lee, Yun Woo, et al.
Publicado: (2021)

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
por: Kamar, Nassim, et al.
Publicado: (2021)

Antibody response to 2- and 3-dose SARS-CoV-2 mRNA vaccination in pediatric and adolescent kidney transplant recipients
por: Crane, Clarkson, et al.
Publicado: (2022)

Absence of Antibody Reponses and Severe COVID-19 in Patients on Hemodialysis Following mRNA Vaccination
por: Michael, Miriam B, et al.
Publicado: (2021)

Fight against COVID-19 with mRNA vaccines and interaction with Dermal fillers
por: Ghasemi, Shohreh, et al.
Publicado: (2021)

Severe rhabdomyolysis secondary to COVID-19 mRNA vaccine in a teenager
por: Pucchio, Aidan, et al.
Publicado: (2022)

Impact of Imprinted Immunity Induced by mRNA Vaccination in an Experimental Animal Model
por: Fujita, Shigeru, et al.
Publicado: (2023)

Effectiveness of COVID-19 Vaccination with mRNA Vaccines for Patients with Cirrhosis in Hungary: Multicentre Matched Cohort Study
por: Drácz, Bálint, et al.
Publicado: (2022)

Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds
por: Simões, Eric A F, et al.
Publicado: (2023)

Durability of anti-spike antibodies after vaccination with mRNA SARS-CoV-2 vaccine is longer in subjects with previous infection: could the booster dose be delayed?
por: Stellini, Roberto, et al.
Publicado: (2022)

Antibody responses to mRNA versus non-mRNA COVID vaccines among the Mongolian population
por: Sereejav, Enkhbold, et al.
Publicado: (2023)

Immunogenicity of a Three-Dose Primary Series of mRNA COVID-19 Vaccines in Patients With Lymphoid Malignancies
por: Sherman, Amy C, et al.
Publicado: (2022)

Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida
por: Giuliano, Anna R., et al.
Publicado: (2022)

Response to mRNA COVID-19 vaccination in three XLA patients
por: Squire, J.D., et al.
Publicado: (2022)

mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study
por: Kohli, Utkarsh, et al.
Publicado: (2022)

Coronavirus disease 2019 (COVID-19) mRNA vaccine effectiveness in asymptomatic healthcare workers
por: Knobel, Pablo, et al.
Publicado: (2021)

Strong SARS-CoV-2 Antibody Response After Booster Dose of BNT162b2 mRNA Vaccines in Uninfected Healthcare Workers
por: Kwon, Seok Ryun, et al.
Publicado: (2022)

Safety and reactogenicity of second booster doses for mRNA vaccines
por: Wilder-Smith, Annelies, et al.
Publicado: (2023)

Levels of Produced Antibodies after Vaccination with mRNA Vaccine; Effect of Previous Infection with SARS-CoV-2
por: Konstantinidis, Theocharis G., et al.
Publicado: (2021)

Myocarditis and pericarditis following mRNA vaccination in autoimmune inflammatory rheumatic disease patients: A single‐center experience
por: Patel, Shreeya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eg6vluucel973a656mu98did4s